Amyloid Complete
Published May 29, 2024 · Recall initiated: May 8, 2024
Summary
FDA records food Class II recall F-1259-2024, published May 29, 2024 and initiated May 8, 2024. Recalling firm: FoodScience, LLC; Status: Terminated; Reported quantity: 72 units; Lot: Lot 549853001 0125 on side panel UPC Code: 0 26664 01505 1. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Contains undeclared crustacean shellfish (shrimp & crab)
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- FoodScience, LLC
- Distributor
- Arizona, California, Kentucky, Washington, Florida
- Lot
- Lot 549853001 0125 on side panel UPC Code: 0 26664 01505 1
- Risk classification
- Class II
- Area (FDA)
- food
- Country
- United States
Related recalls
- FDAMarketside Brioche Rolls, Authentic French Recipe, Net Wt. (.88 OZ (280g)May 29, 2024
- FDASupreme Tradition brand and Marcum brand ground cinnamon. Packaged in 1.5 oz and 2.25 oz clear plastics jarsMay 29, 2024
- FDAMucci Food Products, Ltd. Tiramisu Italian Dessert, 2, 4.25 lb trays per caseMay 29, 2024
- FDAWegman's Half Loaf Garlic BreadMay 29, 2024
- FDAGeissler's Supermarket Shrimp Tempura and Lobster Roll 12 oz.May 29, 2024
- FDAQueso de mano, Fresh soft white cheese, NET WT 24 oz.(640g), Keep Refrigerated, plastic container, packed 12May 29, 2024
Questions about this recall
Was Amyloid Complete recalled?
Yes. FDA published recall F-1259-2024 on May 29, 2024. Reported hazard: Contains undeclared crustacean shellfish (shrimp & crab)
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit